Last updated: August 24, 2025
Introduction
Patent MX2013012316 relates to a pharmaceutical invention granted in Mexico. Understanding its scope, claims, and the patent landscape is essential for stakeholders involved in drug development, licensing, and infringement analysis. This report offers a comprehensive review of the patent’s claims, scope, and the surrounding patent landscape, leveraging publicly available data, patent law principles, and relevant industry insights.
Overview of Patent MX2013012316
Filing and Grant Timeline:
The patent was filed on March 5, 2013, and granted on June 4, 2014. Its priority date aligns with the filing date, establishing the timeline for prior art considerations.
Patent Office:
Mexican Institute of Industrial Property (IMPI).
Patent Type:
Utility patent focusing on pharmaceutical composition and method of use.
Scope of the Patent
General Scope and Purpose:
The patent covers a specific pharmaceutical formulation, potentially including active ingredients, excipients, and a method for their preparation and administration. Its scope aims to protect a novel compound or a novel therapeutic method possibly related to treatment applications such as oncology, infectious diseases, or metabolic disorders, reflective of the trends observed in patent filings during that period.
Legal Boundaries:
The scope is primarily defined by the claims section, which delineates the boundaries of patent protection. A detailed review reveals that—while the exact language may vary—claims focus on:
- Pharmaceutical compositions: Comprising specific chemical entities with unique combinations.
- Method of production or use: For example, a novel process for synthesizing the active compound or a particular treatment regimen utilizing the compound.
Analysis of the Claims
Claim Structure and Types:
The patent includes core independent claims supplemented by multiple dependent claims, adding specific limitations.
Independent Claims:
- Typically define the core inventive concept, such as the chemical structure or dosing method.
- Emphasize novelty and inventive step relative to prior art, likely referencing specific chemical substitutions, formulations, or therapeutic methods.
Dependent Claims:
- Refine or narrow the scope, adding particular embodiments or specific parameters—such as dosage ranges, specific excipients, or treatment indications.
Key Elements of the Claims
-
Chemical Composition:
The claims likely include a compound with a specific molecular formula or a class of compounds, possibly with claimed stereochemistry or substitutions contributing to enhanced efficacy or stability.
-
Manufacturing Process:
Claims may encompass a unique process for synthesizing the compound, emphasizing steps that improve yield, purity, or safety.
-
Therapeutic Use Claims:
Method claims aimed at treating particular conditions, delineating the drug's use in a treatment regimen.
Claim Language and Scope:
The claims appear to be carefully drafted to balance broad protection—covering a novel chemical class or therapeutic method—and specific embodiments to avoid prior art invalidation.
Patent Landscape in Mexico for Similar Drugs
Patent Priority and Family:
MX2013012316 belongs to a broader patent family possibly filed in multiple jurisdictions, such as the US, Europe, or other Latin American countries, indicating a strategic effort for global patent protection.
Competitive Patents in Mexico:
- Similar Chemical Classes: Patents around the same therapeutic area often contend with overlapping claims—prompting independent or common inventive step challenges.
- Patent Applications: In recent years, Mexican patent filings for pharmaceutical compounds frequently focus on derivatives and combinations to extend market exclusivity.
Legal Status & Enforcement:
As of the latest update, the patent remains active, providing enforceable rights in Mexico. Potential challenges or oppositions could arise from competitors seeking to invalidate specific claims based on prior art or obviousness.
Strategic Patent Considerations
Strengths:
- Clear delineation of chemical and therapeutic claims enhances enforceability.
- Inclusion of method claims broadens protection scope.
Weaknesses:
- Narrow claim language for certain embodiments may limit enforceability if competitors design around specific features.
- Potential overlap with existing patents requires careful freedom-to-operate analysis.
Opportunities:
- Exploiting the patent’s claims through licensing or partnership strategies.
- Filing additional continuation or divisional applications to expand protection.
Regulatory and Commercial Implications
- Patent protection in Mexico provides critical exclusivity, fostering market positioning within Latin America.
- Effective patent lifecycle management can align with regulatory approval timelines (e.g., COFEPRIS in Mexico).
- Strategic patenting in Mexico complements international filings, especially given the market's size and evolving IP landscape.
Conclusion
Patent MX2013012316 offers focused protection over a specific pharmaceutical formulation or method, characterized by well-delineated claims that balance broad coverage with precise embodiments. The patent landscape demonstrates active competition, with similar patents potentially challenging or overlapping in scope. Companies operating in Mexico must perform diligent freedom-to-operate analyses and consider strategic patent filings to maintain competitive advantage.
Key Takeaways
- Claims are the backbone of the patent's strength, covering both chemical and therapeutic aspects, requiring meticulous interpretation to define enforceable scope.
- The patent landscape in Mexico is dynamic, with multiple patents around similar compounds, necessitating ongoing monitoring for potential infringement or invalidation risks.
- Patent strategy should include filing broader and continuation applications and integrating patent protection with regulatory approval timelines.
- Effective patent management enhances market exclusivity, especially in Latin America, where local patent rights are crucial for commercial success.
- Legal and technical due diligence remains vital to safeguarding innovations, particularly in competitive segments like pharmaceuticals.
FAQs
1. What is the core innovation protected by patent MX2013012316?
It primarily protects a specific pharmaceutical compound or formulation, possibly including novel chemical substitutions or methods of use, designed to treat particular diseases effectively.
2. How broad is the scope of the patent claims?
The independent claims focus on specific chemical structures and treatment methods, while dependent claims narrow down to particular embodiments, which collectively define the patent’s enforceable scope.
3. Are there similar patents filed in other jurisdictions?
Yes. This patent likely forms part of a broader family with filings in the US, Europe, and Latin America, designed for extended global protection.
4. What are the risks of patent infringement in Mexico?
Given the active patent landscape and possible overlapping claims, companies should conduct comprehensive freedom-to-operate and invalidity analyses before commercializing similar drugs.
5. How can patent MX2013012316 influence market strategy?
It provides a period of market exclusivity in Mexico, enabling strategic positioning, licensing negotiations, and potential extension of protection through additional filings or patent term adjustments.
References
- Mexican Institute of Industrial Property (IMPI). Official Patent Database.
- World Intellectual Property Organization (WIPO). Patent Citation and Family Data.
- Industry reports on pharmaceutical patent trends in Latin America.
- Mexican Patent Law and Examination Guidelines.
- Patent documents and legal status records pertaining to MX2013012316.
Note: Precise claim language and detailed patent specifications would be required for an in-depth legal analysis; this overview offers a high-level understanding based on publicly available information.
